Conversion of Loan Notes

Paris, France and Camberley, UK – 15 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme (“Agreement”) announced on 23 April 2019, it has issued one tranche of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma Group Limited (“Negma”) following the receipt of one conversion notice.  Further details are set out below.

https://novacyt.com/wp-content/uploads/2019/05/Novacyt-Note-Conversion-15-05-19-Tranche-1-conversion-34-ENGLISH.pdf